Devogelaer, Jean‐Pierre

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 1,347

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and Interactions

Cited by 847

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet

Bone health and osteoporosis researchBone health and treatments

Cited by 527

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial

Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism

Bone health and osteoporosis researchBone health and treatments

Cited by 493

Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis

Manicourt, D., Azria, M., Mindeholm, L., Thonar, E. J. ‐., & Devogelaer, J. (2006) · Arthritis & Rheumatism

Osteoarthritis Treatment and MechanismsMusculoskeletal pain and rehabilitation

Cited by 135

Beneficial effects of creatine supplementation in dystrophic patients

Louis, M., Lebacq, J., Poortmans, J. R., Belpaire‐Dethiou, M., Devogelaer, J., Van Hecke, P., Goubel, F., & Francaux, M. (2003) · Muscle & Nerve

Muscle Physiology and DisordersMuscle metabolism and nutrition

Cited by 130

Inhomogeneity of human vertebral cancellous bone: systematic density and structure patterns inside the vertebral body

Banse, X., Devogelaer, J. P., Munting, E., Delloye, C., Cornu, O., & Grynpas, M. (2001) · Bone

Bone health and osteoporosis researchSpinal Fractures and Fixation Techniques

Cited by 130

The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture

Bach, M. A., Rockwood, K., Zetterberg, C., Thamsborg, G., Hébert, R., Devogelaer, J., Christiansen, J. S., Rizzoli, R., Ochsner, J. L., Beisaw, N., et al. (2004) · Journal of the American Geriatrics Society

Hip and Femur FracturesGrowth Hormone and Insulin-like Growth Factors

Cited by 83

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids

Devogelaer, J.-P., Sambrook, P., Reid, D. M., Goemaere, S., Ish-Shalom, S., Collette, J., Su, G., Bucci-Rechtweg, C., Papanastasiou, P., & Reginster, J.-Y. (2013) · Rheumatology

Bone health and osteoporosis researchBone health and treatments

Cited by 19

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate

Sambrook, P. N., Roux, C., Devogelaer, J.-P., Saag, K., Lau, C.-S., Reginster, J.-Y., Bucci-Rechtweg, C., Su, G., & Reid, D. M. (2012) · Bone

Bone health and osteoporosis researchBone health and treatments

Cited by 3